1.00
26.42%
0.209
After Hours:
1.00
Milestone Scientific Inc. stock is traded at $1.00, with a volume of 964.52K.
It is up +26.42% in the last 24 hours and up +28.21% over the past month.
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
See More
Previous Close:
$0.791
Open:
$0.8601
24h Volume:
964.52K
Relative Volume:
7.96
Market Cap:
$77.89M
Revenue:
$8.88M
Net Income/Loss:
$-4.62M
P/E Ratio:
-10.00
EPS:
-0.1
Net Cash Flow:
$-2.66M
1W Performance:
+61.26%
1M Performance:
+28.21%
6M Performance:
+33.33%
1Y Performance:
+24.02%
Milestone Scientific Inc. Stock (MLSS) Company Profile
Name
Milestone Scientific Inc.
Sector
Industry
Phone
973-535-2717
Address
220 South Orange Avenue, Livingston, NJ
Compare MLSS with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
MLSS
Milestone Scientific Inc.
|
1.00 | 77.89M | 8.88M | -4.62M | -2.66M | -0.10 |
ISRG
Intuitive Surgical Inc
|
542.10 | 192.91B | 7.87B | 2.24B | 586.00M | 4.25 |
BDX
Becton Dickinson Co
|
224.25 | 64.77B | 20.18B | 1.73B | 3.07B | 5.51 |
ALC
Alcon Inc
|
87.24 | 43.15B | 9.76B | 1.16B | 665.00M | 0.72 |
RMD
Resmed Inc
|
249.99 | 36.48B | 4.81B | 1.11B | 1.35B | 6.16 |
WST
West Pharmaceutical Services Inc
|
319.35 | 23.17B | 2.88B | 499.60M | 321.60M | 7.41 |
Milestone Scientific Inc. Stock (MLSS) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-16-20 | Initiated | Northland Capital | Market Perform |
Nov-16-18 | Reiterated | Maxim Group | Buy |
Dec-23-16 | Reiterated | Maxim Group | Buy |
Dec-11-15 | Initiated | Maxim Group | Buy |
Milestone Scientific Inc. Stock (MLSS) Latest News
Milestone Scientific announces approval on contract for FSS - TipRanks
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System - The Manila Times
Milestone Scientific Wins Major Federal Contract for CompuFlo® Epidural System | MLSS Stock News - StockTitan
StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS) - MarketBeat
Scientists achieve major milestone with levitating, virtually limitless energy device: 'A feat in and of itself' - MSN
Benchmark Reaffirms Speculative Buy Rating for Milestone Scientific (NYSE:MLSS) - Defense World
Harvard Bioscience (HBIO) Stock Surges Amid Positive Analyst Rat - GuruFocus.com
MLSS (Milestone Scientific) Total Inventories : $3.71 Mil (As of Sep. 2024) - GuruFocus.com
Milestone Scientific Inc. Reports Q3 2024 Financials - MSN
Milestone Scientific announces CEO transition - MSN
Scientists achieve major milestone in quest for nuclear fusion reactor: 'Holy grail of clean energy' - Yahoo! Voices
StockNews.com Begins Coverage on Milestone Scientific (NYSE:MLSS) - MarketBeat
Chainlink Shatters 238-Day Pattern – Wave Count Signals 100% LINK Price Increase - MSN
Uptown office tower in receivership - MSN
XPeng Inc. Sponsored ADR (XPEV) Increases Despite Market Slip: Here's What You Need to Know - MSN
Milestone Scientific Inc. (AMEX:MLSS) Q3 2024 Earnings Call Transcript - Insider Monkey
Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - GuruFocus.com
Milestone Scientific Inc (MLSS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... - Yahoo Finance
Q3 2024 Milestone Scientific Inc Earnings Call Transcript - GuruFocus.com
Milestone Scientific Inc (MLSS) Quarterly 10-Q Report - Quartz
Milestone Scientific CEO to retire, interim successor named By Investing.com - Investing.com Australia
Milestone Scientific earnings missed by $0.01, revenue fell short of estimates - Investing.com UK
Milestone Scientific CEO to retire, interim successor named - Investing.com India
Milestone Scientific CEO Haverhals to Exit; Chairman Goldman Named Interim CEO - MarketWatch
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024 - The Manila Times
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO - The Manila Times
Milestone Scientific Q3 Revenue Jumps 22% on Strong International Dental Sales Growth | MLSS Stock News - StockTitan
Milestone Scientific Announces Leadership Transition and Future Plans - TipRanks
Milestone Scientific Inc (MLSS) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call - The Manila Times
Milestone Scientific (MLSS) to Host Q3 2024 Earnings Call on November 15 | MLSS Stock News - StockTitan
Semler Scientific stock hits 52-week high at $53.39 - Investing.com
Milestone Scientific (NYSE:MLSS) Now Covered by StockNews.com - MarketBeat
Critical Comparison: Pathfinder Cell Therapy (OTCMKTS:PFND) versus Milestone Scientific (NYSE:MLSS) - Defense World
Milestone Scientific (NYSE:MLSS) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Milestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Physician Dr. Elbaz at Hudson Specialty Care - ForexTV.com
Milestone Scientific expands commercial rollout of CompuFlo Epidural System - TipRanks
Lyell Immunopharma Completes Acquisition of ImmPACT Bio - ForexTV.com
Fellow Health Celebrates Milestone of 100,000 Patient Tests - Business Wire
SafetyVue, Inc. Celebrates Milestone Achievements in Construction Safety Training - Yahoo Finance
Health Care | Page 612 of 616 - ROI-NJ.com
Scientific - ழ தொலைக்காட்சி
Milestone Scientific (NYSE:MLSS) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Start-up claims to have ‘successfully’ achieved first ‘chat’ between two dreaming humans: ‘Could unlock new dimensions’ - New York Post
Benchmark Initiates Coverage of Milestone Scientific (MLSS) with Speculative Buy Recommendation - MSN
Milestone Scientific director Leonard Osser sells stock for $100,425 By Investing.com - Investing.com Australia
Milestone Scientific director Leonard Osser sells stock for $100,425 - Investing.com
Leonard Osser Sells 107,984 Shares of Milestone Scientific Inc. (NYSE:MLSS) Stock - MarketBeat
Retina implant partially improved eyesight in people with severe vision loss - STAT
Science Corp’s PRIMA Implant Restores Vision in Preliminary Clinical Trial Results - Business Wire
Milestone Scientific (NYSE:MLSS) Coverage Initiated at StockNews.com - MarketBeat
Milestone Scientific Inc. Stock (MLSS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):